Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulism and bioterrorism: how serious is this problem?

Jirí Patocka1, Miroslav Splino, Vladimír Merka

  • 1University of Defence, Faculty of Military Health Sciences, Department of Toxicology, Hradec Králové, Czech Republic. patocka@pmfhk.cz

Acta Medica (Hradec Kralove)
|August 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticholinesterases Traits Inbuilt in <i>Buxaceae</i> Plant Extracts against Alzheimer's Disease.

Current neuropharmacology·2025
Same author

The psychostimulant drug, fenethylline (captagon): Health risks, addiction and the global impact of illicit trade.

Drug and alcohol dependence reports·2025
Same author

Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Fentanyl and its derivatives: Pain-killers or man-killers?

Heliyon·2024
Same author

Dendrobine: A neuroprotective Sesquiterpenic Alkaloid for the Prevention and Treatment of Diseases: A Review.

Mini reviews in medicinal chemistry·2024
Same author

Health and Environmental Hazards of the Toxic <i>Pteridium aquilinum</i> (L.) Kuhn (Bracken Fern).

Plants (Basel, Switzerland)·2024
Same journal

Transient Occlusion of the Central Retinal Artery in a Patient with Granulomatosis with Polyangiitis.

Acta medica (Hradec Kralove)·2026
Same journal

Growth Hormone-Mediated Diabetic Ketoacidosis: A Rare Presentation of Acromegaly.

Acta medica (Hradec Kralove)·2026
Same journal

Comparison between the Prognosis of Temporomandibular Disorders with and without Accompanying Otologic Symptoms after Non-Invasive Non-Pharmacological Treatment: Controlled Clinical Trial.

Acta medica (Hradec Kralove)·2026
Same journal

Managing Impacted Mandibular Third Molars: A Scoping Review of Surgical Extraction versus Orthodontic Traction and Nerve Injury Risk.

Acta medica (Hradec Kralove)·2026
Same journal

Current and Emerging Approaches to Osseointegration Assessment in Dental Implantology: Limitations, Clinical Utility, and Future Directions.

Acta medica (Hradec Kralove)·2026
Same journal

Structural and Functional Determinants of Oxygen Transport in Exercise: The Role of Total Hemoglobin Mass.

Acta medica (Hradec Kralove)·2026
See all related articles

Botulism is a severe paralytic illness caused by Clostridium botulinum neurotoxin (BTX). Prompt therapy is crucial, as BTX is a potent toxin with potential bioweapon applications but also therapeutic uses.

Area of Science:

  • Neuroscience
  • Microbiology
  • Toxicology

Background:

  • Botulism is a life-threatening disease resulting from neurotoxins produced by Clostridium botulinum.
  • The disease mechanism involves the disruption of acetylcholine release, leading to flaccid paralysis.
  • Three primary forms exist: foodborne, wound, and infant botulism.

Purpose of the Study:

  • To summarize the etiology, pathogenesis, and clinical significance of botulism.
  • To highlight the dual nature of botulinum toxin (BTX) as both a dangerous toxin and a therapeutic agent.

Main Methods:

  • Review of existing literature on Clostridium botulinum and botulism.
  • Analysis of the molecular mechanisms underlying BTX neurotoxicity.
  • Discussion of the public health implications and medical applications of BTX.

Related Experiment Videos

Main Results:

  • Clostridium botulinum produces seven types of homologous neurotoxins, with BTX being the most potent.
  • BTX specifically inhibits acetylcholine release at neuromuscular junctions, causing paralysis.
  • BTX is recognized as a significant bioterrorism threat but also has established medical uses.

Conclusions:

  • Botulism presents a critical public health concern due to the potency of BTX.
  • Understanding the molecular actions of BTX is essential for developing effective treatments and countermeasures.
  • The therapeutic potential of BTX, despite its toxicity, warrants continued investigation.